Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-d-glucose and positron emission tomography: Preliminary study of lung cancer
- 1 October 1990
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 19 (4) , 1005-1010
- https://doi.org/10.1016/0360-3016(90)90026-g
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- UPTAKE OF GA-67-CITRATE AND [2-H-3] DEOXYGLUCOSE IN THE TUMOR-MODEL, FOLLOWING CHEMOTHERAPY AND RADIOTHERAPY1985
- LUNG-TUMOR IMAGING BY POSITRON EMISSION TOMOGRAPHY USING C-11 L-METHIONINE1985
- A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18) - NONTOXIC TRACER FOR RAPID TUMOR-DETECTION1980
- Labeled 2‐deoxy‐D‐glucose analogs. 18F‐labeled 2‐deoxy‐2‐fluoro‐D‐glucose, 2‐deoxy‐2‐fluoro‐D‐mannose and 14C‐2‐deoxy‐2‐fluoro‐D‐glucoseJournal of Labelled Compounds and Radiopharmaceuticals, 1978
- On the Origin of Cancer CellsScience, 1956